Quality Assurance in Rectal Cancer Management
Rectal cancer management has evolved over the past decades. Major improvements in locoregional recurrence rates and survival were made by the introduction of total mesorectal excision (TME). The use of preoperative (chemo)radiation and the possibility of more accurate staging with MRI scanning resulted in further improvements in rectal cancer outcomes.
To further optimise and improve the quality of rectal cancer care, quality assurance in rectal cancer treatment is of great importance. Auditing is an effective instrument to monitor the quality of care and to improve outcome. Other tools to improve the quality of rectal cancer care are for example guideline formation, multidisciplinary team management, and care pathways.
KeywordsQuality assurance Audit Multidisciplinarity Guidelines Quality indicators Cancer registry
- 4.Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373(9666):821–8.PubMedCentralPubMedCrossRefGoogle Scholar
- 10.De Caluwe L, Van NY, Ceelen WP. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2013;(2):CD006041.Google Scholar
- 17.EUROCARE. http://www.eurocare.it. Last accessed 30 Mar 2014.
- 37.Archampong D, Borowski D, Wille-Jorgensen P, Iversen LH. Workload and surgeon’s specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012;(3):CD005391.Google Scholar
- 46.Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;(10):CD001431.Google Scholar